JP2020529999A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020529999A5 JP2020529999A5 JP2020505869A JP2020505869A JP2020529999A5 JP 2020529999 A5 JP2020529999 A5 JP 2020529999A5 JP 2020505869 A JP2020505869 A JP 2020505869A JP 2020505869 A JP2020505869 A JP 2020505869A JP 2020529999 A5 JP2020529999 A5 JP 2020529999A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutically acceptable
- acceptable salt
- iia
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 34
- 150000003839 salts Chemical class 0.000 claims 21
- 208000015181 infectious disease Diseases 0.000 claims 3
- 201000007096 Vulvovaginal Candidiasis Diseases 0.000 claims 2
- -1 4-pyridinyl Chemical group 0.000 claims 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims 1
- 210000003484 anatomy Anatomy 0.000 claims 1
- 150000001735 carboxylic acids Chemical group 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762541370P | 2017-08-04 | 2017-08-04 | |
| US62/541,370 | 2017-08-04 | ||
| PCT/US2018/044619 WO2019028034A1 (en) | 2017-08-04 | 2018-07-31 | Antifungal agents with enhanced activity in acidic ph |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020529999A JP2020529999A (ja) | 2020-10-15 |
| JP2020529999A5 true JP2020529999A5 (https=) | 2021-09-09 |
| JP7214714B2 JP7214714B2 (ja) | 2023-01-30 |
Family
ID=63209698
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020505869A Active JP7214714B2 (ja) | 2017-08-04 | 2018-07-31 | 酸性ｐＨで活性の増強を示す抗真菌剤 |
Country Status (26)
| Country | Link |
|---|---|
| US (3) | US11534433B2 (https=) |
| EP (3) | EP4732902A2 (https=) |
| JP (1) | JP7214714B2 (https=) |
| KR (1) | KR102807716B1 (https=) |
| CN (2) | CN111093655A (https=) |
| AU (2) | AU2018309718B2 (https=) |
| BR (1) | BR112020002290A2 (https=) |
| CA (1) | CA3071940A1 (https=) |
| CY (1) | CY1125690T1 (https=) |
| DK (1) | DK3661503T3 (https=) |
| EA (1) | EA202090445A1 (https=) |
| ES (1) | ES2932658T3 (https=) |
| FI (1) | FI3661503T3 (https=) |
| HR (1) | HRP20221414T1 (https=) |
| HU (1) | HUE060508T2 (https=) |
| LT (1) | LT3661503T (https=) |
| MA (1) | MA49751B1 (https=) |
| MD (1) | MD3661503T2 (https=) |
| MX (1) | MX2020001399A (https=) |
| PL (1) | PL3661503T3 (https=) |
| PT (1) | PT3661503T (https=) |
| RS (1) | RS63746B1 (https=) |
| SI (1) | SI3661503T1 (https=) |
| SM (1) | SMT202200461T1 (https=) |
| TW (1) | TWI805600B (https=) |
| WO (1) | WO2019028034A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112021016876A2 (pt) * | 2019-02-27 | 2021-11-03 | Scynexis Inc | Métodos para tratar e para prevenir pneumonia por pneumocystis, métodos para tratar e para prevenir pneumonia por pneumocystis jirovecii, preparação de um medicamento para tratar ou prevenir pneumonia por pneumocystis jirovecii, e, uso de um composto |
| AU2020276595B2 (en) * | 2019-05-16 | 2025-12-04 | Scynexis, Inc. | Antifungal Agents for Candida Auris Decolonization |
| WO2022140646A1 (en) * | 2020-12-26 | 2022-06-30 | Mycovia Pharmaceuticals, Inc | Dosing regimen for oteseconazole |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5756472A (en) | 1996-01-31 | 1998-05-26 | Merck & Co., Inc. | Antifungal agent obtained from hormonema |
| JP5245057B2 (ja) | 2006-04-03 | 2013-07-24 | メルク・シャープ・アンド・ドーム・コーポレーション | 抗真菌剤 |
| WO2010019204A1 (en) | 2008-08-12 | 2010-02-18 | Merck Sharp & Dohme Corp. | Antifungal agents |
| KR101686075B1 (ko) * | 2008-08-12 | 2016-12-13 | 싸이넥시스, 인크. | 항균제 |
| HRP20220544T1 (hr) | 2015-01-19 | 2022-08-05 | Scynexis, Inc. | Nove soli i polimorfi scy-078 |
| MA49889A (fr) * | 2017-04-10 | 2020-06-24 | Scynexis Inc | Agents antifongiques utilisés en association |
-
2018
- 2018-07-31 KR KR1020207005972A patent/KR102807716B1/ko active Active
- 2018-07-31 BR BR112020002290-0A patent/BR112020002290A2/pt not_active Application Discontinuation
- 2018-07-31 US US16/636,230 patent/US11534433B2/en active Active
- 2018-07-31 CA CA3071940A patent/CA3071940A1/en active Pending
- 2018-07-31 SI SI201830810T patent/SI3661503T1/sl unknown
- 2018-07-31 LT LTEPPCT/US2018/044619T patent/LT3661503T/lt unknown
- 2018-07-31 ES ES18755632T patent/ES2932658T3/es active Active
- 2018-07-31 SM SM20220461T patent/SMT202200461T1/it unknown
- 2018-07-31 EA EA202090445A patent/EA202090445A1/ru unknown
- 2018-07-31 RS RS20221058A patent/RS63746B1/sr unknown
- 2018-07-31 HR HRP20221414TT patent/HRP20221414T1/hr unknown
- 2018-07-31 AU AU2018309718A patent/AU2018309718B2/en active Active
- 2018-07-31 DK DK18755632.9T patent/DK3661503T3/da active
- 2018-07-31 PL PL18755632.9T patent/PL3661503T3/pl unknown
- 2018-07-31 JP JP2020505869A patent/JP7214714B2/ja active Active
- 2018-07-31 EP EP25222120.5A patent/EP4732902A2/en active Pending
- 2018-07-31 PT PT187556329T patent/PT3661503T/pt unknown
- 2018-07-31 MD MDE20200607T patent/MD3661503T2/ro not_active IP Right Cessation
- 2018-07-31 WO PCT/US2018/044619 patent/WO2019028034A1/en not_active Ceased
- 2018-07-31 EP EP18755632.9A patent/EP3661503B1/en not_active Revoked
- 2018-07-31 MA MA49751A patent/MA49751B1/fr unknown
- 2018-07-31 CN CN201880059398.2A patent/CN111093655A/zh active Pending
- 2018-07-31 MX MX2020001399A patent/MX2020001399A/es unknown
- 2018-07-31 CN CN202410653474.XA patent/CN118542868A/zh active Pending
- 2018-07-31 FI FIEP18755632.9T patent/FI3661503T3/fi active
- 2018-07-31 EP EP22193944.0A patent/EP4169514B1/en active Active
- 2018-07-31 HU HUE18755632A patent/HUE060508T2/hu unknown
- 2018-08-03 TW TW107127013A patent/TWI805600B/zh active
-
2022
- 2022-11-18 US US17/990,656 patent/US20230364067A1/en not_active Abandoned
- 2022-12-06 CY CY20221100767T patent/CY1125690T1/el unknown
-
2024
- 2024-10-21 AU AU2024227501A patent/AU2024227501A1/en active Pending
- 2024-12-03 US US18/967,641 patent/US20260000656A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020529999A5 (https=) | ||
| JP2011509295A5 (https=) | ||
| CN101420957B (zh) | 炎症性肠病治疗药 | |
| US20110046190A1 (en) | Combinations comprising a selective cyclooxygenase-2 inhibitor | |
| JP2014516942A5 (https=) | ||
| JP2019218379A5 (https=) | ||
| JP2015517523A5 (https=) | ||
| JP2016507500A5 (https=) | ||
| JP2009511450A5 (https=) | ||
| CN102223882A (zh) | 用于治疗肥厚型心肌病的III 型磷酸二酯酶(PPE III)抑制剂或Ca2+敏化剂 | |
| FI3661503T3 (fi) | PARANTUNEEN AKTIIVISUUDEN HAPPAMASSA pH:SSA OMAAVIA SIENILÄÄKKEITÄ | |
| CN101939001A (zh) | 用于治疗卵巢癌的含有紫杉醇的组合 | |
| JP2020513037A5 (https=) | ||
| JP2010024244A5 (https=) | ||
| JP2014510112A (ja) | オピオイド拮抗体組成物、および強皮症の治療のためのその使用 | |
| TWI901895B (zh) | 一種包含１－（３－氰基－１－異丙基－吲哚－５－基）吡唑－４－甲酸的醫藥組成物 | |
| JP2009532494A5 (https=) | ||
| JPWO2020176527A5 (https=) | ||
| US9084769B2 (en) | Compositions comprising non steroidal anti-inflammatory drugs and methods for use thereof | |
| JPWO2020160316A5 (https=) | ||
| CN101287469A (zh) | 5－(2－氯苯基)－1,2－二氢－7－氟－8－甲氧基－3－甲基－吡唑并[3,4－b][1,4]苯并二氮杂䓬的给药方案 | |
| WO2010143006A1 (en) | Orally bioavailable iron chelators in the treatment of an inflammatory bowel disease | |
| TWI724084B (zh) | 類血管加壓素作用增強劑 | |
| JPWO2020232037A5 (https=) | ||
| JP2025503231A (ja) | ニロガセスタットによる卵巣癌の治療 |